Bullfrog ai announces issuance of australian patent protecting novel prodrugs of mebendazole and their use in treating cancer

Gaithersburg, md., jan. 16, 2024 (globe newswire) -- bullfrog ai holdings, inc. (nasdaq: bfrg; bfrgw) ("bullfrog ai" or the "company"), a technology-enabled drug development company using artificial intelligence (ai) and machine learning to enable the successful development of pharmaceuticals and biologics, today announced that the australian patent office has issued patent no.
BFRG Ratings Summary
BFRG Quant Ranking